Company intelligence / Profile preview
IntraGel Therapeutics
Nazareth, Northern District, Israelintra-gel.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Early clinical results with the SRGel platform delivering cisplatin locally to solid tumors have demonstrated safety and efficacy with minimal-to-no side effects. The company is pursuing a fast-track 505(b)(2) regulatory pathway for its lead product TumoCure in head and neck cancer. Preclinical data support broad compatibility of the platform with most FDA-approved anticancer agents. The company is raising funds to advance into Phase II trials.[1][4][5]
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (notably cisplatin and potentially other anti-cancer drugs)Gel-based drug delivery systems[1][4][10]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Advanced collaboration stages with leading global pharmaceutical companies are mentioned but not named explicitly.[5]
Beyond the preview
Go deeper on IntraGel Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IntraGel Therapeutics.